key: cord-0925492-8ldfn0no authors: Itani, Rania; Karout, Samar; Khojah, Hani M. J.; Jaffal, Fatima; Abbas, Fatme; Awad, Reem; Karout, Lina; Abu‐Farha, Rana K.; Kassab, Mohamad B.; Mukattash, Tareq L. title: Community pharmacists' preparedness and responses to COVID‐19 pandemic: A multinational study date: 2021-06-08 journal: Int J Clin Pract DOI: 10.1111/ijcp.14421 sha: 9edeb8826f59711dbede7b003ff14bdc719100fb doc_id: 925492 cord_uid: 8ldfn0no BACKGROUND: Community pharmacists play a pivotal role in healthcare worldwide. Their role became more critical during the COVID‐19 pandemic. This study aims to investigate the community pharmacists' preparedness and responses to the COVID‐19 pandemic and how efficiently they were prepared to contain and prevent the spread of infection. METHODS: An online questionnaire was distributed to community pharmacists in Saudi Arabia, Lebanon, and Jordan through social media platforms. A scoring system was developed to measure their level of adherence to the preventive measures of the global infection. RESULTS: The total included responses were 800. Around 44% of the pharmacists reported spending less than 15 min/d reading about COVID‐19 updates. Although more than half of them were reviewing official sites, 73% of them were also retrieving information through non‐official channels. Additionally, almost 35% of them were directly contacting customers without physical barriers, 81% reported encountering infected customers, and 12% wore the same facial masks for more than a day. Moreover, 58% of the pharmacies reported the absence of door signs requesting infected customers to declare the infection, 43% of the pharmacies were not limiting the number of simultaneous customers, and 70% were not measuring customers' temperatures prior to entry. Collectively, the mean total score of applied protective measures was 10.12 ± 2.77 (out of 17). CONCLUSION: The level of preparedness of the community pharmacies in these three Middle Eastern countries was not adequate for facing the COVID‐19 pandemic. Health authorities in these countries should closely monitor their adherence to the protective guidelines. before having symptoms and throughout the illness, which draws out the importance of preventing the dissemination of the SARS-CoV-2 infection to mitigate the pandemic. 9 Historically, during outbreaks, community pharmacists have been the first point of contact for the provision of health care services, and they played a substantial role in containing viral outbreaks. For example, community pharmacists participated in administering the influenza vaccine during the influenza outbreak in the United States of America (USA) during 2014 and 2015. 10, 11 During the current COVID-19 pandemic, community pharmacists have also significantly contributed to promoting public health, preventing and managing different medical conditions, ensuring the continuity of patient care and the provision of medications, testing for COVID-19, and advocating for vaccination. 12 Moreover, patients with suspected COVID-19 symptoms usually seek medical help from the most easily accessible health care facilities such as community pharmacies. 13 Therefore, community pharmacists should be appropriately guided and prepared to triage patients presenting with typical and atypical symptoms of COVID- 19. 14 However, the pandemic has created a massive burden on community pharmacists since their professional duties were extended. This is accompanied by the increased pressure of searching for alternative medications since patients often practice medications' stockpiling out of fear of drug shortages in some countries. 15, 16 As providers of pharmaceutical services and free consultations, community pharmacists are being directly exposed to the public, which escalates their risk of acquiring the infection, especially since they are assuming their duties during the lockdown period. [17] [18] [19] [20] [21] Thus, protective measures should be implemented in pharmacy settings to contain the spread of COVID-19. These procedures include adhering to the protective personal equipment (PPE), frequently disinfecting contact surfaces, and maintaining social distancing. Moreover, community pharmacies should limit the number of clients in the pharmacy, instruct them to wear face masks, screen their temperature before entering, and encounter them through a glass barrier. [21] [22] [23] [24] In addition, the use of tele-pharmacy care, which includes the provision of consultations, medication order review, and drug information services, should be encouraged to minimize client visits to the pharmacy, to limit the spread of infection. 25 The use of dietary supplements for the prevention and treatment of COVID-19 is controversial. Yet recent studies have proven a plausible role of vitamin C, vitamin D, and zinc in preventing acute respiratory tract infections, including COVID-19. These supplements have a safe profile, and their use is warranted among individuals with serum deficiencies and those who are at high risk of acquiring COVID-19. [26] [27] [28] [29] [30] It is worth mentioning that the preparedness and response of the pharmacists to COVID-19 in the Middle Eastern community has not yet been thoroughly investigated. A simulated-client study from Saudi Arabia has shown that community pharmacies were not well prepared during the onset of the outbreak. 31 Hence, the main aim of this study was to gain an insight on the pharmacists' awareness of COVID-19 in the Middle Eastern community, identify the degree of implementing the recommended preventive measures during their daily practice, and to pinpoint the sources of information on which they rely to offer their perceived recommendations to suspected COVID-19 patients. This was an observational cross-sectional study that was conducted during November and December 2020. A self-administered What's known • In the Middle East, in addition to providing patients with medications, community pharmacists play a crucial role in providing initial scientific-based health-related information, consultations, and referring patients to physicians. • The role of community pharmacists was further exacerbated by the COVID-19 pandemic where they were at the frontline combating SARS-CoV-2. • This has posed an increased burden and exposure of community pharmacists to the virus which prompts adequate adaptation of preventive methods to minimize the risk. • Therefore, our study aims to evaluate the implementation of preventive methods, preparedness, and responses of the Middle Eastern community pharmacists during the COVID-19 pandemic. • In the literature, there is scanty evidence describing the preparedness of the community pharmacists to respond to the current COVID-19 pandemic. • This paper is the first to investigate thoroughly the preparedness and responses of the Middle Eastern community pharmacists. • In a survey of 800 community pharmacies, pharmacists were found to inadequately implement the infection preventive measures during their practice, and to inappropriately provide recommendations to patients with suspected COVID-19. • This reflects a low level of awareness among the practicing pharmacists. I believe that this paper will be of interest to the readership of your journal because the findings should be relevant in reviewing the compliance to protective regulations in the healthcare sector. • It will also alert policymakers (MOH, OPL, JPA) to support community pharmacists in preventing community transmission, as well as protecting pharmacy personnel. questionnaire was distributed to community pharmacists informally, as only groups on social media platforms were used. These groups included practicing community pharmacists in Lebanon, Jordan, and Saudi Arabia. The shared link to the questionnaire was posted once daily throughout the study period. The questionnaire was revised after it was validated by academics in pharmacy and after being piloted on a sample of 25 pharmacists that were excluded from the total sample. It consisted of four parts: (a) socio-demographic information and pharmacy char- Corp., Armonk, New York, USA) software version 24. Frequencies and ratios were used for categorical variables and mean ± standard deviation for continuous variables of descriptive data. Also, the Shapiro-Wilk test was used for testing all continuous variables for normality before statistical comparisons. In addition, the association between the degree of preventive measures implemented with the independent variables was tested by Kruskal-Wallis and Mann-Whitney U tests. The significance level was set at P ≤ .05 with a confidence interval (CI) of 95%. A score ranging from 0 to 17 was used to count the degree of preventive measures practiced by the community pharmacists, where one mark was counted for each adopted measure of the following: wearing a facemask, frequent handwashing, using sanitizers regularly, disinfecting surfaces and cash, washing white coats frequently, applying a social distancing strategy, avoiding face touch, taking vitamin C, taking zinc, taking vitamin D, receiving this year's flu vaccine, placing a door sign to instruct patients to wear a facemask prior to entering, posting a door sign to inform patients to alert the staff if they are experiencing COVID-19 symptoms, offering free hand sanitizers for patients' use, screening patients' body temperature before entering, limiting the number of clients in the pharmacy, and encountering patients through a physical barrier (either a plexiglass barrier or a dispensing window). Community pharmacists encountering a patient with typical symptoms of COVID-19 should optimally recommend the patient do a polymerase chain reaction (PCR) test. 32 Pharmacists were asked about the primary perceived recommendation to provide when encountering a patient with a suspected COVID-19 infection. Accordingly, the response was considered appropriate when advising the patient to do a PCR test. Guidance from the World Medical Association Declaration of Helsinki was followed in designing and conducting this study. The study protocol was approved by the Institutional Review Board, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan (No. 2020-0833). Pharmacists were requested at the beginning of the study form to approve their participation. The purpose of the study was clearly stated, and they had the right to defer from submitting their response at any time. Confidentiality, anonymity, and non-traceability were strictly maintained. The study included 800 community pharmacists who participated voluntarily from three Arab countries, of whom 115 (14.4%) were from Saudi Arabia, 424 (53%) from Lebanon, and 261 (32.6%) from Jordan. The estimated numbers of community pharmacists practicing in Lebanon, Jordan, and Saudi Arabia are 3762, 8419, and 8214, respectively. [33] [34] [35] The participants' socio-demographic information and pharmacy characteristics in the selected countries are presented in Table 1 . Pharmacists were asked about the primary action taken when dealing with a suspected COVID-19 patient (Figure 1 ), for which Since the onset of the outbreak, community pharmacists have been involved not only in the provision of medications and COVID-19 preventive supplements and medical equipment supplies, but also in raising public awareness and education about COVID-19. 36 For the latter to be attained, the pharmacist should have solid background information on COVID-19. In this study, the greater proportion of community pharmacists spent less than 15 minutes per day to obtain information about COVID-19, which might be due to their overwhelming duties, particularly during the lockdown period. In fact, this might affect the quality, precision, and accuracy of information provided to the public, which is essential for combating Interestingly, more than 73% of the community pharmacists relied on traditional media and social network platforms as a source of information about COVID-19. This finding corroborates recent studies about COVID-19-related information among pharmacists and exhibits the importance of the social network and traditional mass media in information delivery. 38, 39 However, pharmacists need to rely on professional and official medical information to acquire adequate knowledge about COVID-19 that supports them in educating the public without spreading incorrect and misleading information. In Taiwan, for example, health care providers have received COVID-19 updates through formal training sessions. This method has not only provided reliable information to the health care providers but also enhanced their selfconfidence when forwarding the information to the community. 38 On the other hand, health care providers in China, who were not guided and exposed to COVID-19 information in a proper way, had higher levels of anxiety and depression. 40 In our study, it was evident that pharmacists in Saudi Arabia and Jordan are significantly relying on governmental websites, which is considered as a good indicator of the trust in national health care systems in these countries. Although pharmacists in Saudi Arabia have significantly scored higher than the other countries regarding adherence to infection preventive measures, the overall score for the three countries was generally slightly higher than the average score for the scale used. This indicates that most community pharmacies in these countries did not undertake sufficient protective actions to protect pharmacy is widely and freely available for the public, and anyone can set an online appointment for it anytime (usually through the smartphone application). 43 It was also found that participants who worked more than 8 hours, and those who encountered many clients per day, were providing inappropriate recommendations. This might be due to the work overload, exhaustion, and stress during the lockdown period, which can be diminished by having enough personnel to divide the required tasks. Finally, our current study is associated with some limitations. A self-administered online questionnaire was used to collect the data, which would probably demonstrate results that do not reflect the actual behavior of pharmacists. However, this was found as the most convenient method available for data collection during the pandemic. Another potential limitation to this non-probability sampling method is that our findings may not be extrapolated to all Arab countries in the Middle East, where national regulations and pharmacy practice during the COVID-19 outbreak may vary from one country to another. Also, it is worth noting that this study was conducted when the outbreak was at its peak in the Middle East, when community pharmacies were targets for pharmaceutical care due to the fear F I G U R E 1 Pharmacists perceived recommendation for suspected COVID-19 patients (N = 800) of visiting hospitals. This overload on community pharmacists may have greatly affected their responses. Within this study, the performance of community pharmacies in Jordan, Saudi Arabia, and Lebanon during the COVID-19 outbreak was inadequate regarding the application of infection prevention measures. Health authorities in these countries are advised to strengthen surveillance and monitoring activities to ensure better adherence to the regulations. Furthermore, simulated-patient research to evaluate the actual behavior of community pharmacists and the extent to which they are implementing the infection control measures are highly recommended. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses COVID-19: the first documented coronavirus pandemic in history COVID-19) frequently asked questions Coronavirus disease (COVID-19): How is it transmitted? Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics) Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Coronavirus and Surfaces: How Long Does COVID-19 Live on Surfaces? New coronavirus stable for hours on surfaces | National Institutes of Health (NIH) [Internet]. National Institutes of Health The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application The pharmacists' role in disease outbreaks: navigating the dynamics of uncertainty before, during, and after disease outbreaks Fighting against COVID-19: Innovative strategies for clinical pharmacists Community pharmacists' contributions to disease management during the COVID-19 pandemic Media's effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists Providing pharmacy services during the coronavirus pandemic Pharmacists and COVID-19 Community pharmacy and COVID-19-the unsung heroes on our high streets How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal Pharmacists' perception of their role during covid-19: A qualitative content analysis of posts on facebook pharmacy groups in jordan Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China Centers for Disease Control and Prevention. Guidance for Pharmacies Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: results from a national survey Community pharmacy response to infection control during COVID-19. a cross-sectional survey Advice for community pharmacies on COVID-19 -COVID-19 (Coronavirus) Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies Evidence regarding vitamin D and risk of COVID-19 and its severity Mini-review on the roles of vitamin C, vitamin D, and selenium in the immune system against COVID-19 Zinc and respiratory tract infections: perspectives for COVID-19 (Review) Role of vitamin D in preventing of COVID-19 infection, progression and severity The emerging role of vitamin C in the prevention and treatment of COVID-19 Community pharmacy services and preparedness during COVID-19 outbreak in Madinah, Saudi Arabia Overview of Testing for SARS-CoV-2 (COVID-19) Factors associated with quality of life among community pharmacists in Lebanon: results of a crosssectional study The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective A decade in leaps and bounds": pharmacy in Jordan-revisited Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information COVID-19-related information sources and the relationship with confidence in people coping with COVID-19: facebook survey study in Taiwan COVID-19-related knowledge, attitude and practice among hospital and community pharmacists in Addis Ababa Knowledge and perceptions of COVID-19 among health care workers: cross-sectional study Anxiety and depression in frontline health care workers during the outbreak of Covid-19 Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method Community pharmacists' preparedness and responses to COVID-19 pandemic: A multinational study The authors would like to thank Mr Donald W. Flood for proofreading the manuscript and Ms Nawal Kais for her contribution in the data collection. The authors declare no conflicts of interest. The dataset presented in this article is available only upon reasonable request, since it contains confidential information. Requests to access the datasets should be directed to the first author (r.itani@ bau.edu.lb).